New York, N.Y.—March 17, 2014
Mary B. Goldring, PhD, senior scientist at Hospital for Special Surgery (HSS) in New York City, has been named president of the Orthopaedic Research Society (ORS). The inauguration took place at the organization’s annual meeting on March 17 in New Orleans, with more than 2600 attendees.
Dr. Goldring is credited with developing models for the study of human cartilage cell biology. Her research has identified molecular and cellular mechanisms underlying cartilage loss and changes involved in osteoarthritis and inflammatory joint disorders.
The mission of the Orthopaedic Research Society is to advance the global orthopedic research agenda through excellence in research, education, collaboration, communication and advocacy. The ORS has more than 2,800 members, including orthopedic surgeons, research scientists, engineers and biologists.
“It is an honor to be named president of an organization that strives to be the world’s leading forum for the dissemination of new musculoskeletal research findings,” Dr. Goldring said. As president, her goals will include supporting the society’s long-standing mission of delivering outstanding scientific programs. She will also seek to ensure the growth, interactions and long-term retention of the diverse international ORS membership and cultivate young investigators.
Dr. Goldring is currently associate editor of the Journal of Cellular Physiology, Arthritis Research and Therapy, and the Journal of Orthopedic Research. She previously served as co-editor of the journal Arthritis and Rheumatism. In addition, she has served as a member of the Board of Directors of the Osteoarthritis Research Society International and as chair of the Arthritis Foundation Molecular Biology and Genetics Study Section. She has also served on study sections for the National Institutes of Health, the Orthopaedic Research and Educational Foundation, and NASA.
About HSS | Hospital for Special Surgery
HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the eighth consecutive year) and No. 3 in rheumatology by U.S. News & World Report (2017-2018). Founded in 1863, the Hospital has one of the lowest infection rates in the country and was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State. In 2017 HSS provided care to 135,000 patients from 80 countries and performed more than 32,000 surgical procedures. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. The HSS Innovation Institute was formed in 2015 to realize the potential of new drugs, therapeutics and devices; the global standard total knee replacement was developed at HSS in 1969, and in 2017 HSS made 130 invention submissions (more than 2x the submissions in 2015). The HSS Education Institute provides continuing medical curriculum to more than 15,000 subscribing musculoskeletal healthcare professionals in 110 countries. Through HSS Global, the institution is collaborating with medical centers worldwide to advance the quality and value of care and to make world-class HSS care more accessible to more people.